ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Shubik Subcommittee Criticizes New Study Section, Asks NCI To Hire More Epidemiologists

December 5, 1975

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

March 26, 2010

Nutrition Research Priority Areas Outlined By NCI

December 6, 1974

Obey Continue Crusade On Carcinogenesis, Attack On DCCP, Shubik

April 1, 1977

DCE Board Approves Epidemiology Contract Recompetitions

March 17, 1995

Neurosurgeons Say They Wouldn’t Step Into The MRI Van; Should An Asymptomatic Editor?

May 8, 2009